1 unchanged sentence
Securities Trading Plans of Directors and Executive Officers
−Removed: During the three months ended June 30, 2023, none of our directors or executive officers adopted or terminated any contract , instruction or written plan for the purchase or sale of our securities that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) or any “non-Rule 10b5-1 trading arrangement.”
+Added: During the three months ended September 30, 2023, none of our directors or executive officers adopted or terminated any contract , instruction or written plan for the purchase or sale of our securities that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) or any “non-Rule 10b5-1 trading arrangement” as defined in Item 408 of Regulation S-K under the Securities Exchange Act of 1934, as amended.
The exhibits listed on the accompanying index to exhibits are filed or incorporated by reference (as stated therein) as part of this Quarterly Report on Form 10-Q.
5 unchanged sentences
Specimen Common Stock Certificate.
−Removed: Warrant issued to HCP BTC, LLC for the purchase of shares of common stock.
−Removed: Rigel Pharmaceuticals, Inc.
−Removed: 2018 Equity Incentive Plan, as amended.
−Removed: Rigel Pharmaceuticals, Inc.
−Removed: Inducement Plan, as amended.
−Removed: Amendments 1, 2 and 3 to License and Transition Services Agreement with Forma Therapeutics, Inc.
+Added: Executive Severance Plan, as amended.
+Added: Amendment 1 to the License and Collaboration Agreement with Eli Lilly and Company.
Certification required by Rule 13a-14(a) or Rule 15d-14(a) of the Exchange Act.
18 unchanged sentences
(5) Filed as an exhibit to Rigel’s Current Report on Form 10-K dated June 24, 2003, and incorporated herein by reference.
−Removed: (6) Filed as an exhibit to Rigel’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2009, and incorporated herein by reference.
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
2 unchanged sentences
(Principal Executive Officer)
−Removed: August 1, 2023
+Added: November 7, 2023
Chief Financial Officer
(Principal Financial Officer)
−Removed: August 1, 2023
+Added: November 7, 2023
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.